Chiarella et al. [26] documented a significant correlation between subclinical vestibular impairment and anti-TPO antibody titers in euthyroid patients with HT, highlighting that circulating antithyroid autoantibodies may represent a risk factor for developing vestibular dysfunction [26]. The gene discussed is TPO; the disease is hematocrit.